NuVasive | Der Umsatz



Der Umsatz Veränderung Datum
Abbott USD 11.46B 90M 2025-12
AtriCure USD 134.3M 1.8M 2025-09
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.29B 220M 2025-12
Cooper Companies USD 1.07B 4.9M 2025-09
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.57B 20M 2025-12
Globus Medical USD 769M 23.7M 2025-09
Haemonetics USD 338.97M 11.97M 2025-12
Hologic USD 1.05B 0 2025-12
Inogen USD 74.93M 504K 2024-09
Insulet USD 706.3M 57.2M 2025-09
Integra LifeSciences USD 402.06M 13.54M 2025-09
Intuitive Surgical USD 2.87B 360M 2025-12
J&J USD 24.6B 610M 2025-12
Medtronic USD 8.96B 383M 2025-09
Merit Medical Systems USD 384.2M 1.7M 2025-09
Orthofix International USD 799.49M 602.88M 2024-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 249.25M 8.57M 2025-09
Teleflex USD 913M 132.11M 2025-09
Zimmer Biomet Holdings USD 2.24B 240M 2025-12


NuVasive Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.